ChronoScale Corp CHRN
Nasdaq · XNAS · stock · General Industrial Machinery & Equipment, NEC
Chart by TradingView
1/9
Piotroski F — financial health
-44.37
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $12.8M | -$11.7M | $6.8M | -$12.0M | $9.0M |
| 2024 | $17.9M | -$11.3M | $9.5M | -$9.9M | $12.7M |
| 2023 | $18.3M | -$15.2M | $9.1M | -$12.2M | $12.6M |
| 2022 | $12.9M | -$15.1M | $6.2M | -$14.9M | $25.4M |
| 2021 | $11.2M | -$9.8M | $6.7M | -$11.2M | $37.2M |
| 2020 | $8.9M | -$15.8M | $5.1M | -$8.8M | $4.4M |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -44.37 (distress)
- Working capital / assets 0.269
- Retained earnings / assets -13.047
- EBIT / assets -0.663
- Equity / liabilities 0.814
Source: SEC EDGAR filings · CIK 0001549084 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.